Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection

NCT01052259 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

35

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient patient enrollment

Conditions

Chronic Rejection

Interventions

DRUG: Deoxyspergualin

Sponsor

Nippon Kayaku Co., Ltd.